Stock 3417 OHKI HEALTHCARE HOLDINGS CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Ohki Healthcare Holdings Co.,Ltd.

Equities

3417

JP3176900003

Pharmaceuticals

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-05-02 EDT 		5-day change 1st Jan Change
1,020 JPY -0.10% Intraday chart for Ohki Healthcare Holdings Co.,Ltd. +0.89% -5.20%
02-20 Tranche Update on Ohki Healthcare Holdings Co.,Ltd.'s Equity Buyback Plan announced on February 19, 2024. CI
02-20 Ohki Healthcare Holdings Co.,Ltd.'s Equity Buyback announced on February 19, 2024, has closed with 150,000 shares, representing 1.09% for ¥150.30 million. CI

Valuation

Fiscal Period: Marzo 2018 2019 2020 2021 2022 2023
Capitalization 1 23,692 14,088 13,888 17,226 9,889 11,199
Enterprise Value (EV) 1 25,859 14,232 15,842 23,015 14,595 16,421
P/E ratio 10.2 x 6.87 x 5.9 x 6.16 x 10.2 x 5.13 x
Yield 0.83% 1.79% 1.89% 1.6% 2.93% 2.71%
Capitalization / Revenue 0.1 x 0.05 x 0.05 x 0.06 x 0.04 x 0.04 x
EV / Revenue 0.11 x 0.06 x 0.06 x 0.08 x 0.05 x 0.05 x
EV / EBITDA 9.55 x 5.91 x 6.06 x 6.76 x 14.4 x 6.74 x
EV / FCF 5.99 x 5.96 x -7.18 x -4.55 x 11.9 x 265 x
FCF Yield 16.7% 16.8% -13.9% -22% 8.42% 0.38%
Price to Book 1.42 x 0.8 x 0.72 x 0.78 x 0.45 x 0.46 x
Nbr of stocks (in thousands) 14,011 13,990 13,792 13,792 13,792 13,792
Reference price 2 1,691 1,007 1,007 1,249 717.0 812.0
Announcement Date 18-06-29 19-06-20 20-06-29 21-06-25 22-06-29 23-06-28
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Marzo 2018 2019 2020 2021 2022 2023
Net sales 1 239,531 258,481 277,260 286,173 278,162 304,445
EBITDA 1 2,707 2,407 2,616 3,406 1,013 2,435
EBIT 1 2,341 2,036 2,215 3,010 632 2,060
Operating Margin 0.98% 0.79% 0.8% 1.05% 0.23% 0.68%
Earnings before Tax (EBT) 1 3,228 3,050 3,331 4,123 1,532 3,181
Net income 1 2,313 2,050 2,366 2,796 972 2,182
Net margin 0.97% 0.79% 0.85% 0.98% 0.35% 0.72%
EPS 2 165.0 146.5 170.7 202.7 70.48 158.2
Free Cash Flow 1 4,314 2,387 -2,206 -5,062 1,230 61.88
FCF margin 1.8% 0.92% -0.8% -1.77% 0.44% 0.02%
FCF Conversion (EBITDA) 159.37% 99.16% - - 121.37% 2.54%
FCF Conversion (Net income) 186.52% 116.43% - - 126.49% 2.84%
Dividend per Share 2 14.00 18.00 19.00 20.00 21.00 22.00
Announcement Date 18-06-29 19-06-20 20-06-29 21-06-25 22-06-29 23-06-28
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: Marzo 2020 S1 2021 S1 2022 S1 2022 Q3 2023 Q1 2023 S1 2023 Q3 2024 Q1 2024 S1 2024 Q3
Net sales 1 140,256 145,892 141,870 68,404 73,714 152,281 77,323 81,416 167,240 85,429
EBITDA - - - - - - - - - -
EBIT 1 1,005 2,227 588 37 241 716 545 246 1,181 225
Operating Margin 0.72% 1.53% 0.41% 0.05% 0.33% 0.47% 0.7% 0.3% 0.71% 0.26%
Earnings before Tax (EBT) 1 1,549 2,806 1,105 318 510 1,252 810 741 1,986 472
Net income 1 1,079 1,900 731 206 356 870 555 529 1,333 259
Net margin 0.77% 1.3% 0.52% 0.3% 0.48% 0.57% 0.72% 0.65% 0.8% 0.3%
EPS 2 77.50 137.8 53.06 14.92 25.86 63.12 40.27 38.40 96.69 18.79
Dividend per Share - - - - - - - - - -
Announcement Date 19-11-06 20-11-11 21-11-11 22-02-09 22-08-10 22-11-10 23-02-09 23-08-09 23-11-09 24-02-08
1JPY in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: Marzo 2018 2019 2020 2021 2022 2023
Net Debt 1 2,167 144 1,954 5,789 4,706 5,222
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 0.8005 x 0.0598 x 0.7469 x 1.7 x 4.646 x 2.145 x
Free Cash Flow 1 4,314 2,387 -2,206 -5,062 1,230 61.9
ROE (net income / shareholders' equity) 15.2% 12.2% 13.2% 13.9% 4.16% 9.42%
ROA (Net income/ Total Assets) 1.61% 1.29% 1.37% 1.8% 0.36% 1.09%
Assets 1 143,371 158,718 172,776 155,351 272,193 200,404
Book Value Per Share 2 1,190 1,251 1,393 1,611 1,591 1,749
Cash Flow per Share 2 355.0 427.0 290.0 203.0 201.0 235.0
Capex 1 316 402 413 128 91 234
Capex / Sales 0.13% 0.16% 0.15% 0.04% 0.03% 0.08%
Announcement Date 18-06-29 19-06-20 20-06-29 21-06-25 22-06-29 23-06-28
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly earnings - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

1st Jan change Capi.
OHKI HEALTHCARE HOLDINGS CO.,LTD. Stock Ohki Healthcare Holdings Co.,Ltd.
-5.20% 91.28M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+19.98% 43.48B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+20.67% 22.65B
SANDOZ GROUP AG Stock Sandoz Group AG
+14.56% 14.73B
CIPLA LIMITED Stock Cipla Limited
+14.32% 13.79B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+44.72% 12.04B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-8.37% 7.08B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+11.90% 5.47B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 3417 Stock
  4. Financials Ohki Healthcare Holdings Co.,Ltd.